Understanding the Current Rating
The 'Hold' rating assigned to National Peroxide Ltd indicates a cautious stance for investors. It suggests that while the stock may not be an immediate buy, it is not a sell either. This rating reflects a balance of strengths and weaknesses across several key parameters that influence the company’s investment appeal. The rating was adjusted on 17 June 2026, when the Mojo Score declined from 70 to 63, signalling a shift in the company’s overall assessment.
Here’s How the Stock Looks Today
As of 21 July 2026, National Peroxide Ltd’s financial and market data present a nuanced picture. The company operates within the Commodity Chemicals sector and is classified as a microcap, which often entails higher volatility and risk compared to larger peers. The current Mojo Grade of 63 places it firmly in the 'Hold' category, reflecting a moderate outlook.
Quality Assessment
The quality grade for National Peroxide Ltd is below average, primarily due to its weak long-term fundamental strength. Over the past five years, the company has experienced a compound annual growth rate (CAGR) decline of 24.68% in operating profits. This negative trend highlights challenges in sustaining profitability growth. Additionally, the average Return on Equity (ROE) stands at a modest 2.63%, indicating limited efficiency in generating returns from shareholders’ funds. Such figures suggest that while the company is operationally stable, it faces hurdles in delivering robust and consistent earnings growth.
Valuation Perspective
On the valuation front, National Peroxide Ltd appears attractive. The stock trades at a Price to Book Value ratio of 0.9, which is below the average valuation multiples of its peers. This discount suggests that the market currently prices the stock conservatively, potentially offering value to investors who believe in a turnaround or improvement in fundamentals. The company’s ROE has improved slightly to 3.2%, supporting this valuation stance. Moreover, the Price/Earnings to Growth (PEG) ratio is an exceptionally low 0.1, signalling that the stock may be undervalued relative to its earnings growth potential.
Financial Trend and Recent Performance
The financial trend for National Peroxide Ltd is very positive in the short term. The latest quarterly results, as of March 2026, show a remarkable 333.33% growth in net profit, with net sales reaching a quarterly high of ₹85.68 crores and PBDIT (Profit Before Depreciation, Interest and Taxes) at ₹14.88 crores. The operating profit margin to net sales ratio also peaked at 17.37%, reflecting improved operational efficiency. The company has reported positive results for two consecutive quarters, signalling a potential turnaround in profitability despite the longer-term challenges.
Technical Outlook
Technically, the stock exhibits a bullish trend. Over the past three months, National Peroxide Ltd’s share price has surged by 44.70%, and over six months, it has gained 42.93%. Year-to-date returns stand at a healthy 26.07%, although the stock has underperformed over the last year with a decline of 15.12%. This underperformance contrasts with the broader market, where the BSE500 index has seen a marginal negative return of -0.08% over the same period. The recent price momentum suggests growing investor interest, possibly driven by the company’s improving quarterly results and attractive valuation.
Shareholding and Market Capitalisation
National Peroxide Ltd remains predominantly promoter-owned, which often implies stable management control and alignment with shareholder interests. However, as a microcap stock, it may be subject to higher liquidity risk and price volatility compared to larger companies in the sector.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
What This Rating Means for Investors
The 'Hold' rating advises investors to maintain their current positions rather than initiating new purchases or selling off holdings. It reflects a stock that has both potential and risks. The attractive valuation and recent positive financial trends offer reasons for optimism, but the weak long-term fundamentals and below-average quality caution against aggressive buying. Investors should monitor upcoming quarterly results and sector developments closely to reassess the stock’s outlook.
Summary of Key Metrics as of 21 July 2026
National Peroxide Ltd’s stock returns over various periods illustrate mixed performance: a slight dip of -0.02% in the last day, a 2.09% gain over one week, and a robust 44.70% increase over three months. The one-year return remains negative at -15.12%, underscoring recent volatility. The company’s financial strength is highlighted by a very positive short-term trend, with net profit growth exceeding 300% in the latest quarter and improving margins. Valuation metrics remain attractive, with a low Price to Book ratio and PEG ratio signalling potential undervaluation.
Investors should weigh these factors carefully, considering the company’s microcap status and sector dynamics. The current 'Hold' rating by MarketsMOJO reflects this balanced view, suggesting a wait-and-watch approach while keeping an eye on evolving fundamentals and market conditions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
